AISP vs OCC

AISP exhibits severe financial health concerns, with a Piotroski F-Score of 2/9 indicating high distress risk and no Altman Z-Score available, which raises red flags for potential bankruptcy. Despite strong revenue growth of 102.5% YoY and a high gross margin of 50.24%, the company reports a negative operating margin (-9.44%) and ROA of -27.18%, signaling poor operational efficiency. The stock trades at a P/E of 3.46 but has a forward P/E of 17.53, suggesting overvaluation relative to future earnings expectations. Analysts have only one coverage, with a target price of $8.00, but the company has consistently missed earnings estimates, with an average surprise of -358% over the last four quarters.

The company exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. Despite a massive 1-year price surge of 268.6%, this growth is completely decoupled from fundamentals, as the company maintains negative profit margins (-1.01%) and a negative ROE (-3.93%). The high Price-to-Book ratio of 4.78 for a non-profitable entity suggests significant overvaluation. The divergence between the current price and the deterministic health scores indicates a speculative bubble rather than value creation.